Search Results - "Foegh, M"

Refine Results
  1. 1

    Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder by YONKERS, Kimberly A, BROWN, Candace, PEARLSTEIN, Teri B, FOEGH, Marie, SAMPSON-LANDERS, Carole, RAPKIN, Andrea

    Published in Obstetrics and gynecology (New York. 1953) (01-09-2005)
    “…To compare the efficacy of a new low-dose oral contraceptive pill (OCP) formulation with placebo in reducing symptoms of premenstrual dysphoric disorder. This…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial by Archer, David F, Thorneycroft, Ian H, Foegh, Marie, Hanes, Vladimir, Glant, Michael D, Bitterman, Pincas, Kempson, Richard L

    Published in Menopause (New York, N.Y.) (01-11-2005)
    “…OBJECTIVE:The purpose of this multicenter, double-blind, randomized, parallel-group study was to determine the effect of thirteen 28-day cycles of drospirenone…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non- transformed rat vascular smooth muscle cells by Leszczynski, D, Zhao, Y, Luokkamaki, M, Foegh, ML

    Published in The American journal of pathology (01-12-1994)
    “…We examined the effect of several inhibitors/activators of various protein kinases on the proliferation and apoptosis of nontransformed rat coronary vascular…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Estradiol inhibition of arterial neointimal hyperplasia after balloon injury by Foegh, Marie L., Asotra, Satish, Howell, Marcus H., Ramwell, Peter W.

    Published in Journal of vascular surgery (01-04-1994)
    “…Purpose: Estrogens have been shown to protect against cardiovascular disease in postmenopausal women. The mechanisms are unknown. In this study we investigated…”
    Get full text
    Journal Article
  10. 10

    Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression by LOU, H, KODAMA, T, YE JUN ZHAO, MAURICE, P, YI NING WANG, KATZ, N, FOEGH, M. L

    Published in Circulation (New York, N.Y.) (15-12-1996)
    “…Accelerated coronary arteriosclerosis is a major complication in long-term survivors of cardiac transplantation. Estrogen prevents transplant arteriosclerosis…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels by LOU, H, ZHAO, Y, DELAFONTAINE, P, KODAMA, T, KATZ, N, RAMWELL, P. W, FOEGH, M. L

    Published in Circulation (New York, N.Y.) (05-08-1997)
    “…Estrogen protects against cardiovascular disease in both patients and animal models and regulates insulin-like growth factor-I (IGF-I), an important cell-cycle…”
    Get full text
    Journal Article
  13. 13

    L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6 by Lou, H, Kodama, T, Wang, Y N, Katz, N, Ramwell, P, Foegh, M L

    “…L-arginine, a nitric oxide precursor, inhibits myointimal hyperplasia induced by balloon injury in native vessels. No studies are published on L-arginine…”
    Get more information
    Journal Article
  14. 14

    Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I by MOTOMURA, N, LOU, H, MAURICE, P, FOEGH, M. L

    Published in Transplantation (15-04-1997)
    “…We demonstrate here, for the first time, the mitogenic effect of insulin-like growth factor-I (IGF-I) on the development of transplant arteriosclerosis in a…”
    Get full text
    Journal Article
  15. 15

    Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells by Saito, S, Aras, R S, Lou, H, Ramwell, P W, Foegh, M L

    “…We find that chronic estradiol treatment inhibits the development of transplant arteriosclerosis (TA). The mechanism of this inhibition remains unclear. The…”
    Get more information
    Journal Article
  16. 16

    Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression by SAITO, S, FOEGH, M. L, MOTOMURA, N, HONG LOU, KENT, K, RAMWELL, P. W

    Published in Transplantation (15-12-1998)
    “…The etiology of transplant arteriosclerosis is unknown, but current data point to the alloimmune response. Previously, we found that estradiol-17beta (E2) with…”
    Get full text
    Journal Article
  17. 17

    Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts by Cheng, L P, Kuwahara, M, Jacobsson, J, Foegh, M L

    Published in Transplantation (01-12-1991)
    “…A major cause of organ graft loss after heart transplantation is accelerated atherosclerosis. In this study we used aorta allografts and investigated the…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Immunosuppressive effect of emodin, a free radical generator by Huang, H C, Chang, J H, Tung, S F, Wu, R T, Foegh, M L, Chu, S H

    Published in European journal of pharmacology (18-02-1992)
    “…The possible mechanism of immunosuppressive effect of emodin (1,3,8-trihydroxy-6-methylanthraquinone) was investigated in this study. Human mononuclear cells…”
    Get more information
    Journal Article
  20. 20

    Cardiovascular effects of estrogen: implications of the discovery of the estrogen receptor subtype beta by Foegh, M L, Ramwell, P W

    “…In addition to the traditional estrogen receptor-alpha, a second estrogen receptor was recently discovered, namely estrogen receptor-beta. This review focuses…”
    Get full text
    Journal Article